Jeremy Duffield insider trades
Open-market stock purchases and sales by Jeremy Duffield, Chief Scientific Officer at Prime Medicine, Inc, from SEC Form 4 filings since Mar 31, 2023.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- PRME Prime Medicine, Inc: other filings, last Feb 27, 2025